Axsome Therapeutics CEO Tabuteau Herriot Buys, Sells Shares Amid Market Volatility

Axsome Therapeutics, Inc. (AXSM) reports that Director and CEO Tabuteau Herriot has made a series of transactions involving the purchase and sale of shares. On November 3, 2025, the executive bought 91,705 shares at $8.02 per share and sold an equal number of shares at $132.34 per share. The following day, November 4, Tabuteau Herriot purchased 50,459 shares at $8.02 per share and sold the same number of shares at $133.79 per share. On November 5, the executive bought 21,775 shares at $8.02 per share and sold an equal number of shares at $134.49 per share.